Home/Takara Bio/Kazuhisa Matsunaga
KM

Kazuhisa Matsunaga

Director, Senior Managing Executive Officer

Takara Bio

Takara Bio Pipeline

DrugIndicationPhase
TBI-1501Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL)Phase I/II
TBI-1401Glioma (Malignant Brain Tumor)Phase I/II
Regenerative Medicine ProgramsCartilage / OsteoarthritisPreclinical / Early Clinical
rAAV-based Gene Therapy ProgramsUndisclosed Rare DiseasesDiscovery / Preclinical